Agios Pharmaceuticals Inc Stock Price (AGIO)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Dicerna Pharmaceuticals (DRNA) CEO Doug Fambrough on Q1 2021 Results - Earnings Call TranscriptSat, 8 May 2021 08:16:07 UTC via Seeking Alpha
Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2021 Results - Earnings Call TranscriptSat, 8 May 2021 00:22:06 UTC via Seeking Alpha
Prestige Consumer Healthcare Inc. 2021 Q4 - Results - Earnings Call PresentationFri, 7 May 2021 22:56:54 UTC via Seeking Alpha
Diversified Healthcare Trust (DHC) Management on Q1 2021 Results - Earnings Call TranscriptFri, 7 May 2021 20:42:02 UTC via Seeking Alpha
Community Healthcare Trust, Inc. (CHCT) CEO Tim Wallace on Q1 2021 Results - Earnings Call TranscriptFri, 7 May 2021 11:49:07 UTC via Seeking Alpha
Ionis Pharmaceuticals upgraded to neutral from sell at UBSFri, 7 May 2021 09:41:33 UTC via MarketWatch
Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q1 2021 Results - Earnings Call TranscriptFri, 7 May 2021 00:35:36 UTC via Seeking Alpha
ACADIA Pharmaceuticals Inc. 2021 Q1 - Results - Earnings Call PresentationThu, 6 May 2021 20:08:02 UTC via Seeking Alpha
HCA Is A Unique Healthcare PlayThu, 6 May 2021 16:50:08 UTC via Seeking Alpha
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q1 2021 Results - Earnings Call TranscriptThu, 6 May 2021 00:37:05 UTC via Seeking Alpha

Agios Pharmaceuticals Inc Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:AGIO

You don't have any alerts set for IEX:AGIO.

About Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.

CEOJacqualyn A. Fouse IndustryBiotechnology SectorHealthcare Websitehttp://www.agios.com Issue ExchangeNasdaq Global Select Issue TypeUnknown

Real-time AGIO to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.